CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 31 other locations
Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...
Phase 3
Salt Lake City, Utah, United States and 126 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Salt Lake City, Utah, United States and 215 other locations
to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...
Phase 2
Salt Lake City, Utah, United States and 64 other locations
Phase 2 dose (RP2D) in patients with relapsed or refractory (R/R) lymphomas and solid tumors. The secondary objectives are to characterize t...
Phase 1
West Valley City, Utah, United States of America and 1 other location
This trial will study two treatment combinations for classical Hodgkin lymphoma (cHL). This trial will find out if these two treatment combi...
Phase 2
Salt Lake City, Utah, United States and 75 other locations
The purpose of this study was to evaluate whether copanlisib in combination with rituximab is superior to placebo in combination with rituximab in pr...
Phase 3
Salt Lake City, Utah, United States and 188 other locations
This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib...
Phase 3
Salt Lake City, Utah, United States and 226 other locations
of CB-010 in adults with relapsed/refractory B cell non-Hodgkin lymphoma after lymphodepletion consisting of cyclophosphamide and fludarabin...
Phase 1
Salt Lake City, Utah, United States and 29 other locations
plus venetoclax (AV) versus venetoclax plus obinutuzumab (VO) in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma...
Phase 3
Salt Lake City, Utah, United States and 40 other locations
Clinical trials
Research sites
Resources
Legal